Digital Health & AI

SHERIDAN, WYOMING – May 6, 2025 – Stryker (NYSE: SYK), a leading innovator in medical technology, has announced its participation in the highly anticipated Bank of America Securities 2025 Global Healthcare Conference. The event will take place on Tuesday, May 13, 2025, at the Encore at Wynn Hotel in Las Vegas, Nevada. The company’s presentation, set for 1:40 p.m. Pacific Time, will be delivered by Preston Wells, Vice President and Chief Financial Officer, alongside Jason Beach, Vice President, Finance and Investor Relations.

As a global leader in the medical technology sector, Stryker continues to play a pivotal role in shaping the future of healthcare. This participation in the Bank of America Securities 2025 Global Healthcare Conference marks a significant opportunity for the company to showcase its strategic initiatives, innovations, and contributions to improving healthcare outcomes worldwide.

Key Presentation Highlights

SHERIDAN, WYOMING – May 6, 2025 – In a decisive move to address one of the fastest-growing global health threats, the Global Stroke Action Coalition was launched on April 9, 2025, calling on governments worldwide to make stroke a central priority in noncommunicable disease (NCD) strategies. With the global stroke burden projected to rise by 50% over the next 25 years—claiming an estimated 100 million lives and costing USD 1.6 trillion annually—this new multi-sectoral initiative is demanding urgent, evidence-based action.

Strategic Collaboration to Tackle a Growing Crisis

SHERIDAN, WYOMING – May 6, 2025 – GE HealthCare (Nasdaq: GEHC) has announced a strategic expansion of its radiation oncology solutions, unveiling a suite of AI-driven technologies at the ESTRO 2025 Congress in Vienna, Austria. These developments are designed to streamline oncology workflows, accelerate treatment timelines, and improve clinical outcomes—addressing critical priorities in modern cancer care.

With cancer continuing to rank among the world’s leading causes of death, GE HealthCare is positioning itself at the forefront of oncology innovation. The company’s new solutions—ranging from AI-enabled organ segmentation to advanced MR-only radiotherapy workflows—aim to equip clinicians with tools that improve efficiency, precision, and personalization in treatment planning.

Strategic Portfolio Expansion with Spectronic Medical Acquisition

SHERIDAN, WYOMING – May 5, 2025 – Bupa, a global leader in international healthcare, has announced a bold commitment to open 200 new mental health centers—known as “mindplaces”—across the globe over the next three years. This strategic move underscores Bupa’s focus on holistic healthcare and addresses the escalating demand for accessible, high-quality mental health support across its international customer base.

A Strategic Investment in Global Mental Health Infrastructure

This large-scale rollout of mindplaces marks a pivotal shift in how mental healthcare is integrated into the broader healthcare ecosystem. The initiative is aligned with Bupa’s long-term purpose to help people live longer, healthier, happier lives by recognizing mental wellbeing as a core pillar of health.